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INTRODUCTION 
The most challenging task for research scientist is to 
formulate a successful drug product of a poorly soluble 
drug. This occurs mainly because of poor bioavailability. 
Improving oral bioavailability of the drugs which are 
given as solid dosage forms remains a challenge for the 
formulation scientists due to solubility problems1. 
Limited drug absorption resulting in poor bioavailability 
is paramount amongst the potential problems that can be 
encountered when delivering an active agent via the oral 
route2. Poorly water-soluble drugs often show poor 
bioavailability because of low and erratic levels of 
absorption. The rate limiting process for absorption of 
poorly soluble drugs from the solid dosage form could be 
a slow dissolution rate. Various factors affecting the drug 
absorption from gastrointestinal tract are poor aqueous 
solubility or poor membrane permeability. Therefore, 
slow dissolution rate can be overcome by adopting 
various solubility enhancement techniques such as such 
as use of surfactants, complexation, polymorphism, salt 
formation, size reduction and emulsification. Among 
various approaches applied for solubility and 
bioavailability enhancement of poorly water soluble 
drugs solid dispersion is one of the most successful 
method for increasing the drug dissolution rate of the 
drug. 
SOLUBLIZATION TECHNIQUES 
Solubilization is a process of increasing apparent 
solubility of poor water soluble drugs. Such techniques 
mainly includes salt formation, prodrug design, 
complexation, particle size reduction, and the use of 
surface active agents (Micellization), addition of a co-
solvent and various other physicochemical techniques. 
The process of solublization involves the breaking of 
intermolecular and or inters ionic bonds in solute, the 
molecules of solvent separates to provide space for 
solute which leads to interaction between solute and 
solvent. Solubility is an important physic chemical 
property of drug. Solubility behavior of drug forms an 
important aspect for preformulation studies as well. 
Methods to enhance dissolution and absorption rate 
1. Methods increasing solubility 
 Pro drug approach 
 Complexation 
 Use of solvates and hydrates 
 Use of salts of weak acids and weak bases 
 Buffering of pH environment 
2. Methods increasing surface area 
 Micronization 
 Solid dispersion 
 Solvent deposition 
 Use of surfactants 
 Formulation of dispersible tablets 
 
ABSTRACT 
Poor bioavailability of the highly lipophilic drugs is one major challenges being faced in pharmaceutical industry. Poor 
absorption of drug from the oral dosage form could be a result of low dissolution rate. Therefore many techniques have been 
introduced for solubility enhancement out of which Solid Dispersion has attracted considerable interest. Solid dispersion is 
defined as a group of solid products consisting of at least two different components, generally a hydrophilic inert carrier or 
matrix and a hydrophobic drug. It increases the dissolution rate of highly lipophilic drug which leads to increased solubility and 
hence bioavailability of the drug. There are various methods of preparation of solid dispersion like fusion method, solvent 
evaporation, solvent evaporation-deposition, solvent deposition, kneading method, lyophillization, supercritical fluid method. 
Basically this technique includes a drug with poor aqueous solubility and hydrophilic carrier. Polymers incorporated in solid 
dispersion technologies are usually hydrophilic in nature and also showing compatibility with the drug to enhance the drug 
solubility. The present article discusses the basic concept about solid dispersion, various types of solid dispersion, criteria of 
solvent selection, the methods of preparation, characterization, their advantages, limitations and applications. Also this reviews 
about the current trends observed in solid dispersion in past few years and its future prospects. 
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Solid dispersion improves the dissolution rate of the 
poorly water soluble drugs by reducing their particle 
size, improving wettability and forming amorphous 
particles. 
DEFINITION OF SOLID DISPERSION 
The term solid dispersion refers to a group of solid 
products consisting of at least two different components, 
generally a hydrophilic matrix and a hydrophobic drug. 
The matrix can be either crystalline or amorphous. The 
drug can be dispersed molecularly, in amorphous 
particles (clusters) or in crystalline particles1. Molecular 
dispersion of drug in polymeric carriers may lead to 
particle size reduction and surface area enhancement, 
which results improved dissolution rates. This technique 
is one of the oldest and most efficient method of 
enhancing the solubility and bioavailability of poorly 
water soluble drugs. Solid dispersion technology affects 
both specific surface area and solubility. 
Sekiguchi and Obi first reported the increased rate and 
extent of absorption of Sulfathiazole by using solid 
dispersion technique. Nowadays solid dispersion has 
attracted considerable interest and has become choice of 
selection for solubility enhancement of poorly soluble 
drugs. 
Ideal Candidate for Solid Dispersion  
According to Biopharmaceutical classification system, 
Class 2 drugs which have low solubility and high 
permeability are the optimum candidates for solid 
dispersion formulations. This will not only improve 
solubility of the drug but also enhance oral absorption of 
the drug.    
ADVANTAGES OF SOLID DISPERSION 
Various reasons why solid dispersion is chosen as 
method of solubility enhancement are as following: 
 Reduction in particle size :  
When a molecular dispersion is formed, the 
polymer/carrier dissolution takes place in a solvent 
which brings about formation of fine dispersion of drug 
in medium. This leads to high surface area resulting in 
increased dissolution rate and bioavailability. 
 Improves wettability of particles:  
A strong contribution to the enhancement of drug 
solubility is related to the drug wettability improvement 
verified in solid dispersions1. It is observed that carrier 
without any surface active leads to increased activity 
after formation of solid dispersion whereas the carriers 
with surface activity leads much more increase in 
dissolution rate after formulation of solid dispersion. 
 Particles with higher porosity 
There is increase in porosity of particles in solid 
dispersion which mainly depends upon polymer 
properties being used. Linear polymers produce more 
porosity than that of reticular polymers. Hence this leads 
to increase in drug release profile. 
 Drugs in amorphous state 
Drugs in amorphous state show higher solubility than 
crystalline state. The enhancement of drug release can 
usually be achieved using the drug in its amorphous 
state, because no energy is required to break up the 
crystal lattice during the dissolution process3. 
Disadvantages of solid dispersion 
Various limitation of this technique is listed below: 
 Stability of drug and vehicle 
 Difficulty in introducing it into a dosage form 
 Laborious and expensive method of preparation 
 Reproducibility of physicochemical properties
  
 
CLASSIFICATION OF SOLID DISPERSION 
According to the type of carrier, solid dispersion can be classified as following: 
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 FIRST GENERATION 
 First generation solid dispersion uses crystalline 
carriers in formulation of solid dispersion   such as 
sugars and urea. Major disadvantage of crystalline 
carrier is that they form thermodynamically more 
stable form and prevent of the quick release of drug. 
 SECOND GENERATION 
Second generation solid dispersion uses amorphous 
carriers which are mainly polymers. Polymers 
maybe synthetic such as PVP and polyethylene 
glycols or natural based products such as HPMC or 
starch derivatives like cyclodextrin. 
 THIRD GENERATION 
Third generation solid dispersion utilizes carriers 
with surface activity. Therefore surfactants are being 
used such as inulin, inutec SP1,compritol 888 ATO, 
gelucire 44/14 and poloxamer 407, Poloxamer 188. 
 
SELECTION OF CARRIER 
In formulation of solid dispersion of a drug, carrier is 
melted at high temperature and then drug is dispersed in 
it. The properties of a polymer highly affect the solid 
dispersion. Therefore, various characteristics which a 
polymer should possess are as following: 
 Physiologically inert 
 Readily soluble in water and gastrointestinal fluid 
 Melting point should not be much higher than the 
drug 
 Thermal stability at melting temperature 
 Low vapor pressure 
 Non toxic 
 High molecular weight to fulfill the requirement 
Various polymers which are generally used are PEG 
4000, Polyvinly pyrrolidone, HPMC, sugars, citric acid 
etc. 
TYPES OF SOLID DISPERSION 
1. Solid  Solutions 
2. Simple eutectic mixture 
3. Glass solutions and suspensions 
4. Amorphous precipitation in crystalline carriers 
Solid Solutions 
In a solid solution the two components crystallize 
together in a homogeneous one phase system3. As a 
result molecular size of the particle is reduced which 
leads to higher dissolution rate. According to the extent 
of miscibility of the two components, they may be 
classified as continuous or discontinuous. In continuous 
solid solutions, the two components are miscible in the 
solid state in all proportions3. 
Simple Eutectic mixture 
Simple eutectic mixtures are prepared by solidifying the 
melting mixture of two components that show complete 
liquid miscibility. Thermodynamically, such system is an 
intimately blended physical mixture of its two crystalline 
components3. 
Glass solutions and Suspensions 
A glass solution is a homogeneous system in which a 
solute dissolves in the glassy system. A glass suspension 
refers to a mixture in which precipitated particles are 
suspended in a glassy solvent3.Glassy state is brittle and 
transparent below glass transition temperature. 
Amorphous precipitation in crystalline carriers 
In this drug is precipitated out in amorphous forms as 
compared to eutectic mixture . Sulfathiazole was 
precipitated in the amorphous form in crystalline urea.
 
Table 1: Classification of carriers 
CATEGORY EXAMPLES 
1. Sugar  Sucrose, lactose, mannitol, dextrose, sorbitol 
2. Citric acid Succinic acid , Succinic acids 
3. Polymeric materials Povidone Methylcellulose, HPMC Pectin 
4. Surfactants  Polyoxyethylene stearate, Poloxamer  188  Tweens, Spans 
5. Insoluble enteric polymers Eudragit RS, Phthalate, HPMC 
6. Miscellaneous  Urea, urethans, Hydroxyalkylxanthins 
 
METHODS OF PREPARATION 
There are various methods of preparation of solid 
dispersion which has been reported in literature. 
Preparation methods mainly include the mixing of a 
carrier with the drug at molecular level. During the 
preparation of solid dispersion formation of different 
phases and de-mixing is observed. Therefore it was 
observed that extent of phase separation can be 
prevented by Rapid cooling procedure. Phase separation 
can also be prevented by maintaining the driving force 
for phase separation low for example by keeping the 
mixture at an elevated temperature thereby maintaining 
sufficient miscibility for as long as possible4. 
Various techniques for preparation of solid dispersion are 
as following: 
1. Melting  method 
2. Solvent method 
3. Solvent  evaporation-deposition  method 
4. Solvent deposition 
5. Supercritical fluid method 
6. Kneading method 
7. Lyophillization technique 
8. Hot melt extrusion 
9. Use of co-solvents 
10. Melt solvent method 
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1. Melting Method 
It is also known as Fusion Method. In this method carrier 
is selected on the basis of preliminary solubility studies. 
Firstly the carrier is melted in a china dish at 55o - 60o C 
and the drug is added into the melted carrier with 
constant stirring. After this the melted mixture is cooled 
rapidly and stored in desiccators for 24 hours. The 
solidified mass is crushed pulverized and sieved through 
mesh for the desired product.  
Advantages:  
 The main advantage of direct melting method is its 
simplicity and economy.  
 In addition melting under vacuum or blanket of an 
inert gas such as nitrogen may be employed to 
prevent oxidation of drug or carrier  
 Disadvantage: 
 This method can be applied only when the drug and 
the carrier are compatible and they mix well at 
heating temperature. 
 Degradation of drug and carrier can occur during 
heating process, 
 Phase separation can occur. When drug is slowly 
cooled, crystalline form is obtained whereas rapid 
cooling yields amorphous solid dispersion. 
2. Solvent  Evaporation  Method 
The drug and carrier are selected in particular ratios and 
dissolved in common solvent with constant stirring. The 
solution is evaporated continuously under pressure to 
obtain dry mass. The dried mass is pulverized and passed 
through sieve and stored in desiccators. Two challenges 
are mainly faced during formulation by solvent 
evaporation method mainly: 
 To dissolve both drug and carrier in same solvent 
despite of different polarity. 
 To minimize drug particle size in solid dispersion, 
the drug and carrier has to be dispersed in solvent as 
fine as possible. 
 Advantages 
 Thermal decomposition of the drugs can be prevented 
because of low temperature required for organic 
solvents to evaporate. 
 
3. Solvent  Evaporation- Deposition Method 
The drug and carrier are weighed and transferred into a 
solvent system. After complete dissolution a water 
insoluble carrier or an adsorbent is added into the above 
solution. After the ternary system had been completely 
mixed, the solvent is evaporated in water bath at 80o C 
and solid dispersion obtained is crushed, pulverized and 
sieved and stored in desiccators.  
 
4. Solvent Deposition 
The drug is weighed and dissolved in a solvent system. 
After complete dissolution, an adsorbent is added into it. 
After complete mixing, the solvent is evaporated at 80oC. 
The deposits are dried, crushed and sieved to obtain solid 
dispersion formed. 
5. Supercritical Fluid Method 
In this method CO2 is used as either solvent in which 
either drug or matrix is dissolved or either as anti 
solvent. When supercritical CO2 is used as solvent, 
matrix and drug are dissolved and sprayed through a 
nozzle, into an expansion vessel with lower pressure and 
particles are immediately formed. The adiabatic 
expansion of the mixture results in rapid cooling. This 
method does not require any organic solvent due to 
which it is considered as solvent-free method. However, 
the application of this technique is very limited, because 
the solubility in CO2 of most pharmaceutical compounds 
is very low (<0.01wt-%) and decreases with increasing 
polarity2. 
 
6. Kneading Technique5 
A mixture of accurately weighed drug and carrier is 
wetted with solvent and kneaded thoroughly for some 
time in a glass mortar. The paste formed is dried and 
sieved. 
 
7. Lyophillization Technique 
In this technique the drug and carrier are co dissolved in 
a common solvent, frozen and sublimed to obtain a 
lyophilized molecular dispersion. An important 
advantage of freeze drying is that the drug is subjected to 
minimal thermal stress during the formation of the solid 
dispersion6. 
Advantage 
 The risk of phase separation is minimized as soon as 
solution is vitrified. 
8. Hot Melt Extrusion Method6 
Hot-stage extrusion (HME) consists of the extrusion, at 
high rotational speed, of the drug and carrier, previously 
mixed, at melting temperature for a small period of time. 
The resulting product is then collected after cooling at 
room temperature and milled. A reduction in processing 
temperature can be achieved by the association of hot-
stage extrusion with the use of carbon dioxide as a 
plasticizer, which broadens the application of hot-stage 
extrusion to thermally labile compounds. 
 
9. Use of Co-solvent 
Co-solvency is defined as a process in which the 
solubility of the drug is increased by addition of water 
miscible solvents. The added solvents are called as co-
solvents.the solublization effect brought about is 
dependent on the polarity of drug, solvent and co-
solvent. Examples of various co-solvents are propylene 
glycol, polyethylene glycol, ethanol etc. The co-solvents 
basically enhance the solubility in of the drug and reduce 
difference between polarity of the drug and water system 
thereby enhancing the solubility. The mechanism 
involved in solubility enhancement by co-solvency is 
reduction in interfacial tension between aqueous solution 
and hydrophobic solutes and reduces the contact angle 
between liquid and solid.  
 
10. Melt-Solvent Method 
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In this method the drug is dissolved in liquid solvent. 
The solution so formed is incorporated into the   melted 
polymer without removing liquid solvent. 
CURRENT TRENDS OF SOLID DISPERSION IN 
PHARMACEUTICAL INDUSTRY 
The development of solid dispersions of various poor 
water soluble drugs has proved to be an effective 
technique for solubility enhancement. Despite of various 
advantages of this technique, many problems related to 
preparation, formulation, scale–up and stability has been 
encountered in commercial production of water insoluble 
drugs.  
Following is the data regarding formulations of solid 
dispersion of various poor water soluble drugs along 
with its method of preparation and observations 
obtained:
 
Table 2: Data of solid dispersion of various drugs formed with different polymers and different techniques used in 
formulation 
DRUG SOLID 
DISPERSION 
METHOD 
POLYMERS 
USED 
RESULTS Ref 
Midazolam Solvent evaporation 
Co-grinding method 
Fusion method 
Hydroxypropyl-β 
cyclodextrins 
Poloxamer-188 
PEG-4000 
PEG-3350+ 
poloxamer 407 
Solid dispersion with poloxamer-188 in ratio 1:5 by co-
grinding technique was successful in fast release of drug 
when compared to pure drug 
 
 
 
 
7  
Domperidone  Fusion method 
Solvent –melt 
Solvent evaporation 
Sodium alginate  Enhanced aqueous solubility, dissolution rate and 
systemic bioavailability with sodium alginate and 
formulating solid dispersion of the drug. 
 
8 
Pioglitazone HCl Solvent evaporation  PVP K30, HPMC 
PEG 6000 
Eudragit  epo 
Poloxamer 407 
There was 100% drug release with PEG 6000 followed 
by 75% release with PVP K 30 AND 62%  with 
Poloxamer 407 
 
9 
Glimepiride Solvent evaporation PVP K 30 Significant increase in solubility of  the drug was 
observed 
 
10 
Clonazepam  Solvent evaporation 
 
 
PEG6000 
Poloxamer 
HPMA 6cps, HPC  
Highest improvement in wettability & dissolution rate 
with PEG 6000. 
 
 
11 
Itraconazole 
 
 
 
 
 
 
Hot-melt extrusion MethocelTM 
A15 ,E3LV 
 E15LV, E50LV 
E4M, K3LV 
K100LV, K4M 
grades of methyl 
cellulose 
The technique was effectively utilized to prepare 
homogenous solid solutions of E50LV-drug 
characterized as having a single glass transition 
temperature over a wide range of drug loadings 
 
 
12 
Alprazolam  
 
Solvent evaporation 
 
PEG-6000 
PVP K-30 
 
The formulations containing drug and PEG-6000 and 
PVP-K30 at 1:1 revealed similar dissolution profile as 
compared to theoretical dissolution 
 
13 
Carbamazepine 
Spironolactone 
Atorvastatin 
Furosemide 
Fenofibrate 
Etoricoxib 
Ibuprofen, 
Glipizide 
Solvent evaporation 
method 
HPMC 6CPS 
PEG-6000 
Atorvastatin, Furosemide Carbamazepine, Ibuprofen 
responded very well against PEG 6000.    
 
 
14 
 
Mefenamic acid  Solvent evaporation 
 
PEG 
PVP K-30 
HPMC 
Dissolution of MA improved significantly in solid 
dispersion products containing drug: polymer ratio 
2:2:10 (85% in 20 minutes). 
 
15 
Terbinafine 
Hydrochloride 
Solvent evaporation  
Melting method 
PVP K 30 
PEG 6000 
Solid dispersion showed improved dissolution rate than 
pure drug 
 
16 
Dihydroartemisini
n  
( DHA) 
Solvent evaporation 
 
Inclusion complexes 
PVPK30, 
PVPK25, PVPK15) 
Hydroxypropylβextr
in 
DHA solubility was enhanced 
84-fold in DHA-HPβCD complexes and 50-times in 
DHA-PVPK30. 
 
 
17 
 
Ibuprofen  
 
Melting method  
Physical mixtures 
 
Poloxamer-188 
 
Ibuprofen was completely released from the solid 
dispersion 
 
18 
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CHARACTERIZATION OF SOLID DISPERSION 
There are several techniques have been available to 
investigate the molecular arrangement in solid 
dispersions. Several different molecular structures of the 
drug in the matrix can be encountered in solid 
dispersions19. There are many techniques available which 
can detect the amount of crystallinity in dispersion. 
1. Physical Structure 
 Scanning electron microscopy 
  Surface area analysis 
 Surface properties 
  Dynamic vapor sorption 
 Inverse gas chromatography 
 Atomic force microscopy 
  Raman microscopy 
 
2. Drug Carrier miscibility 
  Hot stage microscopy 
  Differential scanning calorimetry 
 Powder X-ray diffraction 
  NMR 1H Spin lattice relaxation time 
 
3. Drug-Carrier Interaction   
 Fourier Transform Infrared Spectroscopy (FTIR) 
 Raman Spectroscopy 
 Solid State NMR 
 
4. Stability 
 Humidity studies 
 Isothermal Calorimetry 
 DSC (Tg, Temperature recrystallization) 
  Dynamic vapor sorption 
 Saturated solubility studies 
 
5. Dissolution enhancement 
 Dissolution 
 Intrinsic dissolution 
 Dynamic solubility 
  Dissolution in bio-relevant media 
 
Fourier Transform Infrared Spectroscopy (FTIR) 
Infrared spectroscopy (IR) is used to detect the variation 
in the energy distribution of interactions between drug 
and matrix. Presence of sharp vibrational bands indicates 
crystallinity. Fourier Transformed Infrared Spectroscopy 
(FTIR) can be used to accurately detect crystallinity 
ranging from 1 to 99% in pure material. It can be carried 
out using KBr pellet. 
Differential Scanning Colorimetery (DSC) 
This technique is used to detect the amount of crystalline 
material. In DSC, samples are heated with a constant 
heating rate and the amount of energy necessary for that 
is detected. With DSC the temperatures at which thermal 
events occur can be detected. Thermal events can be a 
glass to rubber transition, (re)crystallization, melting or 
degradation. Furthermore, the melting- and 
(re)crystallization energy can be quantified. The melting 
energy can be used to detect the amount of crystalline 
material19. 
X-RAY Diffraction 
The XRD is use to determine the material qualitatively 
and the pattern of pure drug exhibits sharp, highly 
intense and less diffused peaks indicating the crystalline 
nature of drug. The lack of sharp peaks in the 
diffractograms of solid dispersions indicates that the drug 
is in the amorphous form in the dispersions. 
In-Vitro Dissolution Studies 
In order to determine dissolution behavior of the drug , 
in-vitro dissolution studies are carried out. This study 
demonstrates the bioavailability or Bioequivalence of   
the drug product through in vitro – in vivo correlation 
(IVIVC). On the other hand if absorption of the drug is 
dissolution rate limited that means the drug in the 
gastrointestinal fluid passes freely through the bio-
membranes at a rate higher than it dissolves or is 
released from the dosage form. The specifically designed 
in-vivo dissolution study will be required in solid 
dispersion system to access the absorption rate, and 
hence its bioavailability and to demonstrate the 
bioequivalence ultimately19. Dissolution studies are 
performed using USP dissolution apparatus, generally 
paddle apparatus in dissolution medium which may be, 
distilled water28 or 0.1 N HCl with or without surfactant 
or Simulated Gastric Fluid pH1.2  or Phosphate buffer.  
Then dissolution rate is estimated20. 
Scanning Electron Microscopy (SEM) 
This technique is used to determine the external 
morphology of the sample. SEM indicates crystallization 
processes and determines the size that with increase with 
an increasing drug content. The disappearance of large 
crystals of drug indicates decrease in crystallinity or 
conversion to amorphous form. 
APPLICATIONS OF SOLID DISPERSION 
There are numerous pharmaceutical applications of solid 
dispersions. The various applications are as following: 
1. To reduce pre-systematic inactivation of drugs like 
morphine and progesterone. 
2. In improving immunosuppressive therapy in lung 
transplant patients, dry powder formulation 
consisting of a solid dispersion for inhalation is 
prepared. It can avoid many problems like use of 
local anesthesia and irritating solvents21. 
3. Solid dispersion system accelerates the onset action 
of drugs which require immediate action like 
NSAIDS. 
4. Dosage forms containing solid dispersions increases 
greater drug  loading per dose  and increases the 
stability of some drugs  
5. Solid dispersion systems were shown to provide bio 
available oral dosage forms for anti-cancer drugs, 
which could be substituted for standard injections to 
improve patient comfort and compliance21. 
6. A solid dispersion system improves absorption 
efficiency thereby reducing in the content of active 
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agent per dose, thus decreasing the cost associated 
with these drug therapies. 
 
CONCLUSION 
Solid dispersion is one of the latest and most effective 
techniques used for enhancement of solubility of poorly 
water soluble drug. Various Methods of preparations as 
described above can be used for formulating the solid 
dispersion. Currently hydrophilic polymers are being 
used in formulation of solid dispersion to achieve the 
goal of solubility enhancement. Solid dispersion has a lot 
of future scope and novel applications in drug delivery 
system which will help in solving the solubility 
problems. 
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